We all read news stories about the difficulties and tensions that the United States has with our allies and even with coalition partners in Iraq, but we rarely read about the good news.

For small businesses, regulatory burdens can be overwhelming.

As I travel around Idaho and visit with seniors, I hear almost universal concern about the rising cost of health care, particularly the cost of prescription drugs.

While nothing is certain, I firmly believe our nation is on the verge of a nuclear energy renaissance.

Japan continues to work closely with the United States on the issue of the North Korean nuclear crisis and has played an important and constructive role in the Six-Party talks.

While American taxes pay for much of the research and development that goes into creating the new, life-saving drugs, American consumers continue to subsidize the cost of the drugs for consumers across the world.

There is no disputing the fact that American consumers pay 30 to 300 percent more for the same prescription drugs as our counterparts in Canada, Europe, and the rest of the world.